Sermorelin

Price range: $54.99 through $449.00

Sermorelin Acetate (GHRH 1-29) is a high-purity (≥99%) synthetic peptide for research. Verified CAS 86168-78-7.

The primary compliant GHRH agonist for investigating pituitary pulsatility, sleep architecture, and neuroendocrine function.

Research Use Only (RUO).

Earn up to 449 points.
SKU: N/A Category:

Description

“These Statements Have Not Been Evaluated By The Food And Drug Administration.
This Product Is Not Intended To Diagnose, Treat, Cure Or Prevent Any Disease.”

 

Sermorelin Acetate (RUO) | GHRH 1-29 Agonist | ≥99% Purity

Prodcut Specification

  • Product Name : Sermorelin Acetate (Research Grade)
  • CAS Number : 86168-78-7
  • Synonyms / Common Names : Sermorelin acetate hydrate 114466-38-5 AKOS040744848
  • Molecular Formula : C151H252N44O45S
  • Molecular Weight : 3436.0 g/mol
  • Peptide Type : Growth Hormone-Releasing Hormone (GHRH) Agonist
  • Target Receptor : GHRH Receptor (GHRHR)
  • Purity : ≥99% (HPLC Verified)
  • Form : Lyophilized White Powder
  • Solubility : Soluble in bacteriostatic water or sterile water
  • Endotoxin Level : Less than 1.0 EU/mg

Disclaimer : For Research Use Only (RUO). Not for human use.

Chemical Identity & “Survivor” Status

Sermorelin (GRF 1-29) is a synthetic polypeptide comprising the first 29 amino acids of endogenous human GHRH. Unlike newer synthetic peptides that have faced regulatory bans, it possesses a unique “Safe Harbor” status in the USA.

Structural Efficiency : It contains the full biological activity of GHRH within the N-terminal 29-amino acid sequence, making it highly specific to the GHRH receptor.

Regulatory Resilience : Because it is the active ingredient of a formerly FDA-approved drug (Geref) that was not withdrawn for safety reasons, it remains the “Last Peptide Standing” for compliant research into the somatotropic axis.

Preservation of Physiology : Unlike exogenous hormones, It stimulates the anterior pituitary to secrete growth hormone in a pulsatile manner.

Chemical structure of Sermorelin Acetate (GRF 1-29)

Verified 2D chemical structure of Sermorelin Acetate (GHRH 1-29) peptide (CAS 86168-78-7), showing the biologically active N-terminal fragment used in pituitary research.

Verified 2D chemical structure of Sermorelin Acetate (GHRH 1-29) peptide (CAS 86168-78-7) showing the biologically active N-terminal fragment for pituitary research.

This synthetic 29-amino acid peptide retains the full biological activity of endogenous GHRH, optimized as an acetate salt for stability and solubility in research protocols.

 

The Physiological Advantage: Sermorelin vs. rhGH vs. Reta

 

It is distinct because it works with the body’s natural feedback loops, specifically the inhibitory control of somatostatin.

Additional information

options

10 mg vial, 10 mg vial with bacteriostatic water, Wholesale set of 10 vials 10 mg each